This study is currently not recruiting participants.

VITROS Immunodiagnostic Products NT-proBNP II Assay Sample Collection Protocol

Investigation of a Diagnostic Assay for Heart Failure

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this clinical study is to collect data to substantiate the use of VITROS NT-proBNP II assay as an aid in the diagnosis of heart failure and in the assessment of the heart failure severity in patients diagnosed with the heart failure.

Detailed description of study

The purpose of this clinical study is to collect data to substantiate the use of VITROS NT-proBNP II assay as an aid in the diagnosis of heart failure and in the assessment of the heart failure severity in patients diagnosed with the heart failure.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: heart failure
  • Age: 100 years or below
  • Gender: All

This study investigates the use of a diagnostic test to help diagnose heart failure and determine how severe it is in patients who have been diagnosed with heart failure. Heart failure is a condition where the heart cannot pump blood as well as it should. The study aims to see how well the test works in assessing heart failure.

Participants in the study will undergo testing with a diagnostic tool that measures specific markers in the blood related to heart function. The results from these tests will help doctors understand the severity of heart failure in patients.

  • Who can participate: Participants must be adults diagnosed with heart failure. Additional eligibility criteria may include stable medical condition and no recent changes in heart failure treatment.
  • Study details: Participants will have their blood tested using a diagnostic tool that measures certain markers related to heart function. No medication or placebo is involved in this study.
Updated on 19 Feb 2024. Study ID: 1712493782

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team